1-18 of 18
Christoph Tinchon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cox Proportional Hazards Deep Neural Network Identifies Peripheral Blood Complete Remission (PB-CR) to be at Least Equivalent to Morphologic CR in Predicting Outcomes of Patients Treated with Azacitidine - a Prospective Cohort Study By the AGMT

Lisa Pleyer, Marc Vaisband, Michael Pfeilstocker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Michael Girschikofsky, Margarete Stampfl-Mattersberger, Christoph Tinchon, Bernd L. Hartmann, Andreas Petzer, Martin Schreder, Clemens A. Schmitt, Sonia Vallet, Thomas Melchardt, Lukas Scagnetti, Armin Zebisch, Sigrid Machherndl-Spandl, Dominik Wolf, Felix Keil, Jan Hasenauer, Richard Greil
Journal: Blood
Blood (2022) 140 (Supplement 1): 1346–1349.
https://doi.org/10.1182/blood-2022-168521
Published: 2022
Journal Articles

Randomized Comparison between Krd and Ktd Induction, Followed By K Maintenance or Control in Transplant Non-Eligible Patients with NDMM: Efficacy and Qol Data (AGMT-MM02 Trial)

Heinz Ludwig, Thomas Melchardt, Siegfried Sormann, Niklas Zojer, Johannes Andel, Bernd L. Hartmann, Christoph Tinchon, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Martin Schreder, Reinhard Ruckser, Boris Bozic, Maria-Theresa Krauth, Andreas Petzer, Clemens A. Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, Stefan Knop, Sarah Kainz, Bruno Paiva, Richard Greil
Journal: Blood
Blood (2022) 140 (Supplement 1): 10185–10188.
https://doi.org/10.1182/blood-2022-162336
Published: 2022
Journal Articles

Peripheral Blood Complete Remission Provides Added Value to the Classical Definition of Morphologic Complete Remission - a Prospective Cohort Study of 1441 Patients with MDS, CMML and AML Treated within the Austrian Azacitidine Registry

Lisa Pleyer, Michael Pfeilstocker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Michael Girschikofsky, Margarete Stampfl-Mattesberger, Christoph Tinchon, Bernd Hartmann, Andreas Petzer, Branka Petricevic, Clemens A. Schmitt, Sonja Vallet, Klaus Geissler, Wolfgang R. Sperr, Michael Leisch, Alexander Egle, Thomas Melchardt, Gudrun Piringer, Armin Zebisch, Sigrid Machherndl-Spandl, Dominik Wolf, Felix Keil, Hubert Angermann, Manuel Drost, Julian Larcher-Senn, Richard Greil
Journal: Blood
Blood (2021) 138 (Supplement 1): 3387.
https://doi.org/10.1182/blood-2021-145401
Published: 2021
Journal Articles

Composition of the Immune Environment at Baseline Correlates with Time to Response and Treatment Outcome in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (MM) Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Observation (AGMT_MM 02 Study)

Irene Manrique, Richard Greil, Johannes Andel, Siegfried Sormann, Bernd L. Hartmann, Klaus Podar, Alexander Egle, Andreas Petzer, Niklas Zojer, Eberhard Gunsilius, Reinhard Ruckser, Boris Bozic, Clemens A. Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Martin Schreder, Song-Yau Wang, Wolfgang Willenbacher, Maria-Theresa Krauth, Christoph Tinchon, Michael Fillitz, Thomas Melchardt, Stefan Knop, Bruno Paiva, Heinz Ludwig
Journal: Blood
Blood (2021) 138 (Supplement 1): 1669.
https://doi.org/10.1182/blood-2021-150311
Published: 2021
Journal Articles

The EQ-5D-5L Predicts Treatment Outcomes and Provides Added Value to the R-IPSS in Patients with MDS, CMML or AML Treated within the Austrian Azacitidine Registry - a Prospective Cohort Study By the AGMT Study Group

Lisa Pleyer, Sonja Heibl, Christoph Tinchon, Sonja Vallet, Branka Petricevic, Michael Leisch, Alexander Egle, Thomas Melchardt, Gudrun Piringer, Dominik Wolf, Richard Beswick, Manuel Drost, Julian Larcher-Senn, Thomas Grochtdreis, Richard Greil, Reinhard Stauder
Journal: Blood
Blood (2021) 138 (Supplement 1): 64.
https://doi.org/10.1182/blood-2021-145281
Published: 2021
Journal Articles

Immunophenotyping of Baseline Bone Marrow Reveals a Specific Pattern of Immune Cells Associated with Greater Depth and Sustained Response in Newly Diagnosed Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Control (AGMT MM 02 Study)

Irene Manrique, PhD, Richard Greil, MD, Johannes Andel, MD, Siegfried Sormann, MD, Bernd L. Hartmann, MD, Klaus Podar, MDPhD, Alexander Egle, MD, Andreas Petzer, MD, Niklas Zojer, MD, Reinhard Ruckser, MD, Boris Bozic, MD, Clemens A. Schmitt, MD, Sigrid Machherndl-Spandl, MD, Hermine Agis, MD, Martin Schreder, MD, Maria-Theresa Krauth, MD, Christoph Tinchon, MD, Michael Fillitz, MD, Thomas Melchardt, MD PhD, Bruno Paiva, PhD, Heinz Ludwig, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-140918
Published: 2020
Journal Articles

Quality of Life in Newly Diagnosed Patients with Multiple Myeloma Randomized to Either Krd or Ktd Induction Therapy Followed By Carfilzomib Maintenance or Control (AGMT MM 02 trial)

Heinz Ludwig, MD, Thomas Melchardt, MD PhD, Johannes Andel, MD, Eberhard Gunsilius, MD, Siegfried Sormann, MD, Axel Hinke, PhD, Bernd L. Hartmann, MD, Klaus Podar, MDPhD, Wolfgang Willenbacher, MD PhD, Alexander Egle, MD, Andreas Petzer, MD, Niklas Zojer, MD, Ewald Wöll, MD, Reinhard Ruckser, MD, Boris Bozic, MD, Clemens A. Schmitt, MD, Sigrid Machherndl-Spandl, MD, Maria-Theresa Krauth, MD, Martin Schreder, MD, Hermine Agis, MD, Christoph Tinchon, MD, Michael Fillitz, MD, Richard Greil, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–29.
https://doi.org/10.1182/blood-2020-140701
Published: 2020
Journal Articles

Carfilzomib-Revlimid-Dexamethasone Vs. Carfilzomib-Thalidomide-Dexamethasone Weekly (After 2 Twice Weekly Cycles) Followed By Carfilzomib Maintenance Vs. Control in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) - Interim Efficacy Analysis of Combined Data (AGMT MM-02)

Heinz Ludwig, MD, Siegfried Sormann, Niklas Zojer, Johannes Andel, Bernd L. Hartmann, Christoph Tinchon, MD, Eberhard Gunsilius, MD, Klaus Podar, MD PhD, Alexander Egle, MD, Wolfgang Willenbacher, MD PhD, Ewald Wöll, MD, Reinhard Ruckser, MD, Boris Bozic, MD, Maria-Theresa Krauth, MD, Andreas Petzer, MD, Clemens A. Schmitt, MD, Sigrid Machherndl-Spandl, MD, Hermine Agis, MD, Bruno Paiva, PhD, Richard Greil, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 696.
https://doi.org/10.1182/blood-2019-127954
Published: 2019
Journal Articles

Expanding on Current Definitions of Hematologic Improvement in MDS, CMML and AML: Landmark Analyses of 1301 Patients Treated with Azacitidine in the Austrian Registry of Hypomethylating Agents By the AGMT-Study Group

Lisa Pleyer, Michael Pfeilstocker, MD, Reinhard Stauder, MD MSc, Sonja Heibl, MD, Heinz Sill, MD, Michael Girschikofsky, MD, Margarete Stampfl-Mattersberger, MD, Christoph Tinchon, MD, Andreas Petzer, MD, Clemens A. Schmitt, MD, Sonia Vallet, MD, Inga Mandac, MD, Klaus Geissler, MD, Wolfgang R. Sperr, MD, Michael Leisch, MD, Alexander Egle, MD, Thomas Melchardt, MD PhD, Julia Fusinato, BSc, Gudrun Piringer, MD MSc, Armin Zebisch, MD, Sigrid Machherndl-Spandl, MD, Dominik Wolf, MD, Felix Keil, MD, Richard Greil, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3821.
https://doi.org/10.1182/blood-2019-128153
Published: 2019
Journal Articles

Autologous Stem Cell Transplantation with Benda-BEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin´s Lymphoma

Thomas Noesslinger, MD, Michaela Moestl, MD, Christoph Tinchon, MD, Elisabeth Koller, MD, Werner Linkesch, Univ. Prof, MD, Felix Keil, MD
Journal: Blood
Blood (2014) 124 (21): 3982.
https://doi.org/10.1182/blood.V124.21.3982.3982
Published: 2014
Journal Articles

Azacitidine in Patients with Relapsed/Refractory Acute Myeloid Leukemia : Retrospective Analysis of the Austrian Azacitidine Registry

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 943.
https://doi.org/10.1182/blood.V124.21.943.943
Published: 2014
Journal Articles

Azacitidine in Patients with Treatment-Related Acute Myeloid Leukemia: Retrospective Analysis of the Austrian Azacitidine Registry

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 2284.
https://doi.org/10.1182/blood.V124.21.2284.2284
Published: 2014
Journal Articles

Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 955.
https://doi.org/10.1182/blood.V124.21.955.955
Published: 2014
Journal Articles

Azacitidine in Patients with Acute Myeloid Leukemia: Assessing the Potential Negative Impact of Elevated Baseline White Blood Cell Count on Outcome

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 3683.
https://doi.org/10.1182/blood.V124.21.3683.3683
Published: 2014
Journal Articles

Azacitidine in Acute Myeloid Leukemia: Comparison of Patients with AML-MRF Vs AML-NOS Enrolled in the Austrian Azacitidine Registry

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 3681.
https://doi.org/10.1182/blood.V124.21.3681.3681
Published: 2014
Journal Articles

Report on Response and Overall Survival of 128 Unselected, Consecutive AML Patients From the Austrian Azacitidine Registry (AAR) of the AGMT-Study Group

Lisa Pleyer, MD, DI, Reinhard Stauder, MD, Sonja Burgstaller, MD, Martin Schreder, MD, Christoph Tinchon, MD, Michael Pfeilstocker, MD, Susanne Steinkirchner, MD, Thomas Melchardt, MD, Martina Mitrovic, Michael Girschikofsky, MD, Alois Lang, MD, Peter Krippl, MD, Thamer Sliwa, MD, Alexander Egle, MD, Werner Linkesch, MD, Michael A. Fridrik, MD, Richard Greil, MD
Journal: Blood
Blood (2011) 118 (21): 4266.
https://doi.org/10.1182/blood.V118.21.4266.4266
Published: 2011
Journal Articles

Activity of Azacitidine in 26 Unselected, Consecutive CMML Patients Included in the Austrian Azacitidine Registry (AAR) of the AGMT-Study Group

Lisa Pleyer, MD, DI, Reinhard Stauder, MD, Sonja Burgstaller, MD, Martin Schreder, MD, Christoph Tinchon, MD, Michael Pfeilstöcker, MD, Susanne Steinkirchner, MD, Thomas Melchardt, MD, Martina Mitrovic, Michael Girschikofsky, MD, Alois Lang, MD, Peter Krippl, MD, Alexander Egle, MD, Thamer Sliwa, MD, Werner Linkesch, MD, Michael A. Fridrik, MD, Richard Greil, MD
Journal: Blood
Blood (2011) 118 (21): 1715.
https://doi.org/10.1182/blood.V118.21.1715.1715
Published: 2011
Journal Articles

A functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndrome

Clinical Trials & Observations
Albert Wölfler, Stefan J. Erkeland, Claudia Bodner, Marijke Valkhof, Wilfried Renner, Christina Leitner, Werner Olipitz, Michael Pfeilstöcker, Christoph Tinchon, Werner Emberger, Werner Linkesch, Ivo P. Touw, Heinz Sill
Journal: Blood
Blood (2005) 105 (9): 3731–3736.
https://doi.org/10.1182/blood-2004-06-2094
Published: 2005